13F-HR filed by Affinity Asset Advisors, LLC
Affinity Asset Advisors, LLC filed this 13F-HR for the quarter ended 2022-03-31, filed 2022-05-13, with 59 holding rows worth $625,043,000.
- Accession
- 0001387131-22-006128
- Filer
- CIK 1773195
- Filed
- 2022-05-13
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q1 2022
A holdings report, 59 entries on the cover page, a total value of $625,043,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $625,043,000 with VALUE read as thousands by filing date, 13F file number 028-20754. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| SPY | 78462F103 | SHS | 750,000 | $338,730,000 | thousands by filing date | put |
| INARI MED INC | 45332Y109 | COM | 220,000 | $19,941,000 | thousands by filing date | |
| MORPHIC HLDG INC | 61775R105 | COM | 465,654 | $18,696,000 | thousands by filing date | |
| KURA ONCOLOGY INC COM | 50127T109 | Stock | 924,147 | $14,860,000 | thousands by filing date | |
| ASCENDIS PHARMA A/S DKK 1.0 AD | 04351P101 | SPONSORED ADR | 120,000 | $14,083,000 | thousands by filing date | |
| SPRINGWORKS THERAPEUTICS INC | 85205L107 | COM | 247,000 | $13,941,000 | thousands by filing date | |
| CHINOOK THERAPEUTICS INC | 16961L106 | COM | 845,155 | $13,827,000 | thousands by filing date | |
| ESTABLISHMENT LABS HOLDINGS | G31249108 | COMMON STOCK | 174,500 | $11,760,000 | thousands by filing date | |
| TRAVERE THERAPEUTICS INC | 761299AB2 | NOTE 2.500% 9/1 | 11,000,000 | $11,495,000 | thousands by filing date | principal |
| ASTRAZENECA PLC SPONSORED ADR | 046353108 | ADR | 160,000 | $10,614,000 | thousands by filing date | |
| ZENTALIS PHARMACEUTICALS INC | 98943L107 | COMMON STOCK | 207,500 | $9,574,000 | thousands by filing date | |
| SPRINGWORKS THERAPEUTICS INC | 85205L107 | COM | 160,000 | $9,030,000 | thousands by filing date | put |
| NANOSTRING TECHNOLOGIES INC | 63009RAD1 | BOND | 7,000,000 | $7,753,000 | thousands by filing date | principal |
| MADRIGAL PHARMACEUTICALS INC COM | 558868105 | Stock | 75,000 | $7,359,000 | thousands by filing date | |
| PROTAGONIST THERAPEUTICS | 74366E102 | COM | 300,000 | $7,104,000 | thousands by filing date | |
| ARYA SCIENCES ACQUISITN CORP | G31658100 | CLASS A ORD SHS | 702,500 | $6,828,000 | thousands by filing date | |
| REPARE THERAPEUTICS INC | 760273102 | COM | 468,905 | $6,677,000 | thousands by filing date | |
| PMV PHARMACEUTICALS INC | 69353Y103 | COM | 317,400 | $6,608,000 | thousands by filing date | call |
| LANTHEUS HLDGS INC | 516544103 | COM | 115,000 | $6,361,000 | thousands by filing date | |
| NANOSTRING TECHNOLOGIES INC | 63009R109 | COM | 171,592 | $5,963,000 | thousands by filing date | |
| VINCERX PHARMA INC | 92731L106 | COM NEW | 1,374,098 | $5,496,000 | thousands by filing date | |
| PROTAGONIST THERAPEUTICS | 74366E102 | COM | 215,900 | $5,113,000 | thousands by filing date | put |
| ROCKET PHARMACEUTICALS INC | 77313F106 | COM | 300,000 | $4,758,000 | thousands by filing date | |
| Bridgebio Pharma Inc Note 2.250 percent 2/0 | 10806XAD4 | Convertible | 10,000,000 | $4,680,000 | thousands by filing date | principal |
| BRIDGEBIO PHARMA INC | 10806XAB8 | NOTE 2.500% 3/1 | 7,500,000 | $4,380,000 | thousands by filing date | principal |
| CELLDEX THERAPEUTICS INC NEW | 15117B202 | COM NEW | 125,000 | $4,258,000 | thousands by filing date | |
| BELLUS HEALTH INC NEW | 07987C204 | COM | 600,000 | $4,128,000 | thousands by filing date | |
| CYMABAY THERAPEUTICS INC | 23257D103 | COM | 1,272,244 | $3,957,000 | thousands by filing date | |
| CRISPR THERAPEUTICS AG NAMEN AKT | H17182108 | Stock | 55,000 | $3,452,000 | thousands by filing date | call |
| HORIZON THERAPEUTICS PLC | G46188101 | SHS | 30,000 | $3,156,000 | thousands by filing date | |
| HEALTH SCIENCES ACQ CORP 2 | G4411D109 | ORD SHS | 300,000 | $2,973,000 | thousands by filing date | |
| MEDICUS SCIENCES ACQUISITION | G5960S108 | CL A SHS | 300,000 | $2,934,000 | thousands by filing date | |
| TRAVERE THERAPEUTICS INC | 89422G107 | COM | 100,000 | $2,577,000 | thousands by filing date | |
| CEREVEL THERAPEUTICS HLDNG I | 15678U128 | COM | 70,000 | $2,451,000 | thousands by filing date | |
| XENON PHARMACEUTICALS INC COM | 98420N105 | Stock | 80,000 | $2,446,000 | thousands by filing date | |
| NAUTILUS BIOTECHNOLOGY INC | 63909J108 | COM | 559,019 | $2,426,000 | thousands by filing date | |
| GLOBAL BLOOD THERAPEUTICS USD | 37890U108 | COM | 70,000 | $2,425,000 | thousands by filing date | |
| RELAY THERAPEUTICS INC COM | 75943R102 | Stock | 75,000 | $2,245,000 | thousands by filing date | call |
| LANTHEUS HLDGS INC | 516544103 | COM | 40,000 | $2,212,000 | thousands by filing date | put |
| AURINIA PHARMACEUTICALS INC COM | 05156V102 | Stock | 175,000 | $2,167,000 | thousands by filing date | call |
| ACLARIS THERAPEUTICS INC COM | 00461U105 | Stock | 100,000 | $1,724,000 | thousands by filing date | |
| BEAM THERAPEUTICS INC | 07373V105 | COM | 30,000 | $1,719,000 | thousands by filing date | call |
| CONTEXT THERAPEUTICS INC | 21077P108 | COM | 777,610 | $1,687,000 | thousands by filing date | |
| CYCLACEL PHARMACE 6percent PFDCONV | 23254L603 | Stock | 400,000 | $1,220,000 | thousands by filing date | |
| LIANBIO ADR | 53000N108 | COM | 325,000 | $1,206,000 | thousands by filing date | |
| SCIENCE 37 HOLDINGS INC | 808644108 | COM | 221,382 | $1,184,000 | thousands by filing date | |
| KARUNA THERAPEUTICS INC | 48576A100 | COM | 7,500 | $951,000 | thousands by filing date | |
| VIRIDIAN THERAPEUTICS INC | 92790C104 | COM | 50,000 | $925,000 | thousands by filing date | |
| ATHERSYS INC | 04744L106 | COM | 1,416,400 | $858,000 | thousands by filing date | put |
| RENOVACOR INC | 75989E106 | COM | 199,490 | $846,000 | thousands by filing date | |
| CURIS INC | 231269200 | COM | 350,000 | $833,000 | thousands by filing date | |
| CELULARITY INC | 151190105 | COM | 80,000 | $697,000 | thousands by filing date | put |
| CENTESSA PHARMACEUTICALS PLC | 152309100 | SPONSORED ADS | 65,282 | $586,000 | thousands by filing date | |
| CALITHERA BIOSCIENCES INC COM NEW | 13089P101 | Stock | 1,000,000 | $404,000 | thousands by filing date | |
| IMMATICS N.V | N44445117 | *W EXP 07/01/202 | 187,204 | $328,000 | thousands by filing date | |
| HYPERFINE INC | 44916K106 | Common Stock | 76,162 | $270,000 | thousands by filing date | |
| BLUEPRINT MEDICINES CORP | 09627Y109 | COM | 1,988 | $127,000 | thousands by filing date | |
| Renovacor Inc | 75989E114 | Warrant | 75,000 | $26,000 | thousands by filing date | |
| MEDICUS SCIENCES ACQUISITION | G5960S124 | *W EXP 02/12/202 | 33,333 | $14,000 | thousands by filing date |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001387131-22-006128 | this filing | 2022-05-13 | acceptance time not in the bulk data set |